![Peter Altman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Altman
Verkställande Direktör på
BIOCARDIA, INC.
Förmögenhet: 277 387 $ per 2026-05-31
Profil
Peter Alan Altman was the founder of CareDx, Inc., founded in 1998, where the title held was Director from 2003 to 2014.
Dr. Altman was the founder of Lumen Therapeutics, founded in 2004, where the title held was Chief Executive Officer from 2004 to 2005.
Dr. Altman is also the founder of Sinus Rhythm Technologies, Inc...
Dr. Altman is currently President, Chief Executive Officer & Director at BioCardia, Inc. since 2002.
Dr. Altman is Chief Executive Officer at BioCardia Lifesciences, Inc. Dr. Altman is Director at Oncocyclist Biotech since 2018.
Former jobs include President, Chief Executive Officer & Director at BioCardia, Inc. and Principal at Ventritex, Inc. Education includes a doctorate from the University of California, Berkeley, a doctorate from The University of California, San Francisco, and undergraduate and graduate degrees from Fu Foundation School of Engineering & Applied Science.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
BIOCARDIA, INC. 2,62 % | 2026-06-09 | 298 266 ( 2,62 % ) | 277 387 $ | 2026-05-31 |
Aktiva positioner av Peter Altman
| Företag | Position | Start |
|---|---|---|
| BIOCARDIA, INC. | Verkställande Direktör | 2002-01-01 |
Oncocyclist Biotech | Direktör/Styrelseledamot | 2018-01-01 |
BioCardia Lifesciences, Inc.
 BioCardia Lifesciences, Inc. BiotechnologyHealth Technology Develops therapeutics for cardiovascular diseases | Verkställande Direktör | - |
Tidigare kända positioner av Peter Altman
| Företag | Position | Slut |
|---|---|---|
| CAREDX, INC. | Grundare | 2014-01-01 |
Lumen Therapeutics
 Lumen Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Verkställande Direktör | 2005-01-01 |
BioCardia, Inc. /Old/
 BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Verkställande Direktör | - |
Ventritex, Inc.
 Ventritex, Inc. Medical SpecialtiesHealth Technology Designs, develops and sells cadence implantable defibrilators | Företagsledare/Principal | - |
Sinus Rhythm Technologies, Inc.
 Sinus Rhythm Technologies, Inc. Medical SpecialtiesHealth Technology Develops devices for the prevention of atrial fibrillation | Företagsledare/Principal | - |
Peter Altmans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
32
Första gradens relationer
11
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 11 |
|---|---|
Ventritex, Inc.
Ventritex, Inc. Medical SpecialtiesHealth Technology Designs, develops and sells cadence implantable defibrilators | Health Technology |
CareDx, Inc.
 CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sinus Rhythm Technologies, Inc.
Sinus Rhythm Technologies, Inc. Medical SpecialtiesHealth Technology Develops devices for the prevention of atrial fibrillation | Health Technology |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Health Technology |
Lumen Therapeutics
Lumen Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Fu Foundation School of Engineering & Applied Science
 Fu Foundation School of Engineering & Applied Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioCardia, Inc.
 BioCardia, Inc. BiotechnologyHealth Technology Develops biotherapeutics for cardiovascular disease | Health Technology |
BioCardia Lifesciences, Inc.
BioCardia Lifesciences, Inc. BiotechnologyHealth Technology Develops therapeutics for cardiovascular diseases | Health Technology |
Oncocyclist Biotech |
